Alan Mendelson > Latham & Watkins LLP > Silicon Valley, United States > Lawyer Profile

Latham & Watkins LLP
CA 94025
United States


Alan Mendelson represents emerging and public growth companies, primarily in the life sciences industry. He served as the Co-chair of the firm’s Emerging Companies Practice from 2001 to 2013 and currently is Co-chair of the Life Sciences Industry Group. Mr. Mendelson has handled and supervised a variety of major business transactions.


Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

(Hall of Fame)

Alan MendelsonLatham & Watkins LLP

With an impressive client roster of blue-chip pharmaceutical, biotech and medical devices companies, Latham & Watkins LLP has excellent transactional credentials including buy- and sell-side M&A, capital markets transactions, and commercial deals including high-value licensing. The team handled a steady flow of multimillion-dollar capital markets transactions for clients including Guardant Health, Gritstone Oncology, Gossamer Bio and Satsuma Pharmaceuticals. Recent highlights include representing Agenus in its $1.7bn strategic alliance with Gilead Sciences and acting for Puma Biotechnology and certain of its executives in a securities class action and shareholder derivative suit filed in the US District Court for the Central District of California. Nathan Ajiashvili is particularly recommended for advising financial institutions and public and private companies on equity and debt capital markets transactions, as are Alan MendelsonBrian CuneoMark RoederCheston Larson and Peter HandrinosJudith Hasko handles licensing, joint ventures and other technology and IP-based transactions, and John Manthei focuses on regulatory matters and recently represented Catalyst Pharmaceuticals in suing the FDA over approval of cheaper rival drug Ruzurgi. The team is spread across New York, Silicon Valley, Boston, San Diego, Washington DC, and Orange County.

United States > M&A/corporate and commercial > Venture capital and emerging companies

(Hall of Fame)

Alan MendelsonLatham & Watkins LLP

Latham & Watkins LLP‘s team is ‘cohesive from coast to coast‘, and stands out for its strength in assisting clients with all aspects of the life-cycle of emerging companies. Technology and life sciences are notable areas of expertise for the group; recent highlights include advising Neurogene on its $68.5m Series A financing round, in order to develop gene therapy programs. Boston-based John Chory and Benjamin Potter in Silicon Valley co-lead the emerging companies practice. In Silicon Valley, Patrick Pohlen and life sciences expert Alan Mendelson are also key contacts. Boston-based Susan Mazur is also recommended.